Filana Therapeutics, Inc.(FLNA)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
FLNA is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.30.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±4.2%).
Did the stock rise after good news?
The next-day move after each of its last 7 EPS beats and 4 misses.
In plain words: it beat expectations 7 times, but the stock still fell 3 of those 7 times.
- May '26Beat▼ -5.6%
- Mar '26Beat▼ -6.7%
- Nov '25Beat▲ +4.8%
- Mar '25Beat▲ +3.3%
- Nov '24Beat▼ -4.6%
- Aug '24Missed▼ -13.8%
- May '24Beat▲ +1.9%
- Feb '24Missed▼ -0.3%
- Nov '23Beat▲ +4.3%
- Aug '23Missed▼ -0.7%
- May '23Missed▲ +0.5%
Clear beats and misses with a known reaction only. What counts as a beat
Why did FLNA fall after beating earnings?
4 of FLNA's last 11 reactions went against the EPS result. What stands out in each:
FLNA beat EPS estimates in 7 quarters, and the stock still closed lower the next day 3 times. In 1 of the 3 where we have price data, the stock had already run up before the report.
- May 7, 2026EPS beat +8.7%stock -5.6% next day
- It opened 1.4% lower as soon as trading resumed.
- Mar 12, 2026EPS beat +13.3%stock -6.7% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 7, 2024EPS beat +34.1%stock -4.6% next day
- It had risen 6.3% in the 20 trading sessions before the report, so good news may already have been priced in.
Rose despite an EPS miss (1 of 4)
- May 1, 2023EPS missed -3.6%stock +0.5% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was FLNA's earnings move already priced in?
FLNA's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does FLNA hold its opening gap after earnings?
FLNA's opening move after each report and where it closed that day.
In 6 reports FLNA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 6 times (17%). Gaps up faded 0 of 3; gaps down recovered 1 of 3.
- May 7, 2026HeldOpened -1.4%, closed -5.6%
- Mar 3, 2025HeldOpened +2.1%, closed +3.3%
- Aug 8, 2024HeldOpened -4.8%, closed -13.8%
- May 10, 2024HeldOpened +1.3%, closed +1.9%
- Nov 7, 2023HeldOpened +1.2%, closed +4.3%
- Aug 3, 2023FadedOpened -1.5%, closed -0.7%
What the history says
- FLNA has beaten EPS estimates in 6 straight quarters.
- It fell after 3 of its 7 EPS beats (43%): beating estimates has not been enough on its own.
FLNA earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Before open | -$0.22 | -$0.18 | +18.2% | — | — |
| May 7, 2026 | Before open | -$0.23 | -$0.21 | +8.7% | -5.56% | -11.11% |
| Mar 12, 2026 | Before open | -$0.30 | -$0.26 | +13.3% | -6.70% | -6.70% |
| Nov 12, 2025 | Before open | -$0.27 | -$0.22 | +18.5% | +4.82% | -11.25% |
| Mar 3, 2025 | Before open | -$0.68 | -$0.57 | +16.2% | +3.33% | +15.00% |
| Nov 7, 2024 | Before open | -$0.88 | -$0.58 | +34.1% | -4.63% | +1.84% |
| Aug 8, 2024 | Before open | -$0.40 | -$1.28 | -220.0% | -13.84% | -27.05% |
| May 10, 2024 | After close | -$0.46 | -$0.43 | +6.5% | +1.93% | +13.74% |
| Feb 28, 2024 | Before open | -$0.40 | -$0.50 | -25.0% | -0.30% | 0.00% |
| Nov 7, 2023 | Before open | -$0.90 | -$0.61 | +32.2% | +4.30% | -1.82% |
| Aug 3, 2023 | Before open | -$0.58 | -$0.63 | -8.6% | -0.67% | -9.68% |
| May 1, 2023 | Before open | -$0.56 | -$0.58 | -3.6% | +0.52% | -3.92% |
Consensus for the next report: EPS -$0.30, revenue $0.00.
FLNA Earnings FAQ
Answers computed from Filana Therapeutics, Inc.'s reported history
FLNA is scheduled to report on Nov 11, 2026, usually before the market opens. Analysts expect EPS of -$0.30.
Over the last 12 quarters with a usable EPS surprise, FLNA beat the consensus estimate 8 times (67%), missed 4 and landed in line 0. It has beaten estimates in each of the last 6 counted quarters.
Across its last 11 quarters with a measured reaction, FLNA moved an average of ±4.2% in the first session after reporting. It closed higher 46% of the time; the largest gain was 4.8% and the largest drop -13.8%.
FLNA fell in the first session after 3 of its last 7 EPS beats (43%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, FLNA moved an average of +10.5% in the 20 trading sessions before reporting and was higher in 36% of them. After a run-up of 3% or more (3 quarters), it fell the next day 67% of the time, averaging -4.7%. After a drop of 3% or more (7 quarters), it rose the next day 43% of the time, averaging -0.9%. This describes past reports; it is not a forecast.
In 6 reports FLNA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 6 times (17%), and fully reversed 0 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · FLNA: 12 reported quarters, latest Jul 29, 2026. Information only, not investment advice.
Looking for more on FLNA?
Price charts, forecast, fundamentals and risk pages for FLNA are not on Tickzen yet. You can run a full stock analysis now.
Run the FLNA Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun